Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2011 Jan 15;377(9761):242-50.
doi: 10.1016/S0140-6736(10)61889-2. Epub 2011 Jan 5.

High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial

Adrian R Martineau  1 , Peter M Timms, Graham H Bothamley, Yasmeen Hanifa, Kamrul Islam, Alleyna P Claxton, Geoffrey E Packe, John C Moore-Gillon, Mathina Darmalingam, Robert N Davidson, Heather J Milburn, Lucy V Baker, Richard D Barker, Nicholas J Woodward, Timothy R Venton, Korina E Barnes, Christopher J Mullett, Anna K Coussens, Clare M Rutterford, Charles A Mein, Geraint R Davies, Robert J Wilkinson, Vladyslav Nikolayevskyy, Francis A Drobniewski, Sandra M Eldridge, Christopher J Griffiths
Affiliations
Randomized Controlled Trial

High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial

Adrian R Martineau et al. Lancet. .

Abstract

Background: Vitamin D was used to treat tuberculosis in the pre-antibiotic era, and its metabolites induce antimycobacterial immunity in vitro. Clinical trials investigating the effect of adjunctive vitamin D on sputum culture conversion are absent.

Methods: We undertook a multicentre randomised controlled trial of adjunctive vitamin D in adults with sputum smear-positive pulmonary tuberculosis in London, UK. 146 patients were allocated to receive 2·5 mg vitamin D(3) or placebo at baseline and 14, 28, and 42 days after starting standard tuberculosis treatment. The primary endpoint was time from initiation of antimicrobial treatment to sputum culture conversion. Patients were genotyped for TaqI and FokI polymorphisms of the vitamin D receptor, and interaction analyses were done to assess the influence of the vitamin D receptor genotype on response to vitamin D(3). This trial is registered with ClinicalTrials.gov number NCT00419068.

Findings: 126 patients were included in the primary efficacy analysis (62 assigned to intervention, 64 assigned to placebo). Median time to sputum culture conversion was 36·0 days in the intervention group and 43·5 days in the placebo group (adjusted hazard ratio 1·39, 95% CI 0·90-2·16; p=0.14). TaqI genotype modified the effect of vitamin D supplementation on time to sputum culture conversion (p(interaction)=0·03), with enhanced response seen only in patients with the tt genotype (8·09, 95% CI 1·36-48·01; p=0·02). FokI genotype did not modify the effect of vitamin D supplementation (p(interaction)=0·85). Mean serum 25-hydroxyvitamin D concentration at 56 days was 101·4 nmol/L in the intervention group and 22·8 nmol/L in the placebo group (95% CI for difference 68·6-88·2; p<0·0001).

Interpretation: Administration of four doses of 2·5 mg vitamin D(3) increased serum 25-hydroxyvitamin D concentrations in patients receiving intensive-phase treatment for pulmonary tuberculosis. Vitamin D did not significantly affect time to sputum culture conversion in the whole study population, but it did significantly hasten sputum culture conversion in participants with the tt genotype of the TaqI vitamin D receptor polymorphism.

Funding: British Lung Foundation.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Trial Profile
Figure 2
Figure 2. Time to sputum culture conversion by allocation.
Error bars, 95% confidence intervals. The number of participants with positive sputum culture remaining in follow-up (number at risk) at 0, 2, 4, 6 and 8 weeks is presented (36).
Figure 3
Figure 3
A. Serum 25-hydroxyvitamin D concentration by allocation at baseline and 8 weeks. B. Mean urinary calcium: creatinine molar ratio by allocation at baseline and 2, 4, 6 and 8 weeks. Error bars, standard errors of the mean. C. Mean serum corrected calcium by allocation at baseline and 2, 4, 6 and 8 weeks. Error bars, standard errors of the mean.
See this image and copyright information in PMC

Comment in

References

    1. WHO . Global tuberculosis control: a short update to the 2009 report. Geneva: 2009.
    1. Maartens G, Wilkinson RJ. Tuberculosis. Lancet. 2007 Dec 15;370(9604):2030–43. - PubMed
    1. Rook GA, Steele J, Fraher L, Barker S, Karmali R, O’Riordan J, et al. Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology. 1986;57(1):159–63. - PMC - PubMed
    1. Rockett KA, Brookes R, Udalova I, Vidal V, Hill AV, Kwiatkowski D. 1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line. Infect Immun. 1998 Nov;66(11):5314–21. - PMC - PubMed
    1. Sly LM, Lopez M, Nauseef WM, Reiner NE. 1alpha,25-Dihydroxyvitamin D3-induced monocyte antimycobacterial activity is regulated by phosphatidylinositol 3-kinase and mediated by the NADPH-dependent phagocyte oxidase. J Biol Chem. 2001 Sep 21;276(38):35482–93. - PubMed

Methods References

    1. Martineau AR, Nanzer AM, Satkunam KR, Packe GE, Rainbow SJ, Maunsell ZJ, et al. Influence of a single oral dose of vitamin D(2) on serum 25-hydroxyvitamin D concentrations in tuberculosis patients. Int J Tuberc Lung Dis. 2009 Jan;13(1):119–25. - PubMed
    1. National Collaborating Centre for Chronic Conditions . Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. Royal College of Physicians; London: 2006. - PubMed
    1. Kubica GP, Dye WE, Cohn ML, Middlebrook G. Sputum digestion and decontamination with N-acetyl-L-cysteine-sodium hydroxide for culture of mycobacteria. Am Rev Respir Dis. 1963 May;87:775–9. - PubMed
    1. Collins CH, Grange JM, Yates MD. Tuberculosis bacteriology. 2nd ed. Butterworth-Heinemann; Oxford: 1997.
    1. Maunsell Z, Wright DJ, Rainbow SJ. Routine Isotope-Dilution Liquid Chromatography–Tandem Mass Spectrometry Assay for Simultaneous Measurement of the 25-Hydroxy Metabolites of Vitamins D2 and D3. Clin Chem. 2005;51(9):1683–90. - PubMed

Publication types

Associated data